A safe and affordable treatment to slow the advancement of Parkinson's dementia has emerged – in the form of a commonly available cough syrup that's already being studied for its positive effect on ...
In a small clinical trial in Canada, a medicine commonly found in European cough syrups has shown early signs it might do something no approved treatment for Parkinson’s disease dementia has yet ...
Today’s cough syrup could turn into tomorrow’s treatment for Parkinson’s disease. Recent research in the U.K. is the latest to suggest that a common ingredient in cough syrup, ambroxol, might be able ...
Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over 12 months, whereas placebo patients worsened. Those with high-risk genes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results